Previous studies have investigated MMP-2, MMP-9, MMP-10, and TIMP-1 and TIMP-2 levels in CSF of AD patients with and without lobar microbleeds, which can be considered hallmarks of CAA [27]. This evidence concerns the gene MMP2 and Alzheimer disease.